“…Dear editor, Drs. Paramesh and Zwaal suggest that any trial of activated protein C should be conducted independently of the drug manufacturer or anyone with financial links to the manufacturer, and without the involvement of anyone previously involved in trials of activated protein C [1]. This suggestion has great merit and we encourage Drs.…”